http://www.berkeleywellness.com/healthy … n-be-legal
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/Last year, we reported on the use of the hallucinogenic drugs MDMA and psilocybin to ease symptoms in people with post-traumatic stress disorder (PTSD) and treatment-resistant depression. Since then, evidence has continued to mount that these drugs, when administered in controlled therapeutic settings, may be able to succeed where traditional pharmaceuticals have fallen short in the treatment of each condition. One of them, in fact—MDMA—is currently on track for FDA approval.
MDMA’s ability to increase feelings of trust and compassionhas made it a popular party drug, and that attribute may also make it an unusually effective complement to psychotherapy in people with PTSD. In a small, placebo-controlled study of PTSD sufferers published in the Journal of Psychopharmacology, for instance, researchers found that the drug, administered during two eight-hour psychotherapy sessions spaced about a month apart, reduced symptoms for the majority of participants; a follow-up study in the same journal found that the effects lasted up to six years in some cases.
it's almost like ken was right ... and you're just massively ignorant. /shrugMental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a paradigmatic crisis. A radical innovation is psychedelic-assisted psychotherapy (PAP): professionally supervised use of ketamine, MDMA, psilocybin, LSD and ibogaine as part of elaborated psychotherapy programs. Clinical results so far have shown safety and efficacy, even for “treatment resistant” conditions, and thus deserve increasing attention from medical, psychological and psychiatric professionals. But more than novel treatments, the PAP model also has important consequences for the diagnostics and explanation axis of the psychiatric crisis, challenging the discrete nosological entities and advancing novel explanations for mental disorders and their treatment, in a model considerate of social and cultural factors, including adversities, trauma, and the therapeutic potential of some non-ordinary states of consciousness.